CGAS, cyclic GMP-AMP synthase, 115004

N. diseases: 40; N. variants: 3
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0004623
Disease: Bacterial Infections
Bacterial Infections
0.010 Biomarker group BEFREE Cyclic dinucleotides are second messengers in the cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING) pathway, which plays an important role in recognizing tumor cells and viral or bacterial infections. 31715099 2019
CUI: C0015967
Disease: Fever
Fever
0.010 Biomarker phenotype BEFREE These findings show for the first time the involvement of the cGAS-STING-IRF3 route in ASFV infection, where IFN-β production or inhibition was found after infection by attenuated or virulent ASFV strains, respectively, thus reinforcing the idea that ASFV virulence versus attenuation may be a phenomenon grounded in ASFV-mediated innate immune modulation where the cGAS-STING pathway might play an important role.<b>IMPORTANCE</b> African swine fever, a devastating disease for domestic pigs and wild boar, is currently spreading in Europe, Russia, and China, becoming a global threat with huge economic and ecological consequences. 30918080 2019
CUI: C0022660
Disease: Kidney Failure, Acute
Kidney Failure, Acute
0.010 AlteredExpression disease BEFREE Cisplatin induced mtDNA leakage into the cytosol-probably through BCL-2-like protein 4 (BAX) pores in the mitochondrial outer membrane-in tubules, with subsequent activation of the cGAS-STING pathway, thereby triggering inflammation and AKI progression, which is improved in STING-deficient mice. 31665638 2019
CUI: C0024115
Disease: Lung diseases
Lung diseases
0.010 GeneticVariation group BEFREE Lung disease in STING N153S mice developed independently of cGAS, IRF3/IRF7, and IFNAR1. 30772497 2019
CUI: C0024793
Disease: Marek Disease
Marek Disease
0.010 Biomarker disease BEFREE This study demonstrates that the cGAS-STING DNA-sensing pathway is critical for the induction of the IFN-β response against MDV infection in chicken fibroblasts and macrophages. 30518647 2019
CUI: C0178874
Disease: Tumor Progression
Tumor Progression
0.010 Biomarker phenotype BEFREE This study suggests that it is necessary to deeply and fully evaluate the function of cGAS/STING signaling in cancer immunity and cancer progression before the application of the STING agonist-based anticancer immune therapy in the clinic. 30583098 2019
CUI: C1269955
Disease: Tumor Cell Invasion
Tumor Cell Invasion
0.010 Biomarker phenotype BEFREE Mechanistically, we demonstrate that inhibition of HR repair by cGAS is linked to its ability to self-oligomerize, causing compaction of bound template dsDNA into a higher-ordered state less amenable to strand invasion by RAD51-coated ssDNA filaments. 31544964 2019
CUI: C0023418
Disease: leukemia
leukemia
0.010 Biomarker disease BEFREE Importantly, we demonstrate using mice lacking DDX41 or cGAS that both sensors are needed for the full antiviral response needed to control <i>in vivo</i> MLV infection. 29871919 2018
CUI: C0024530
Disease: Malaria
Malaria
0.010 Biomarker disease BEFREE We used a nonlethal murine model of malaria (Plasmodium yoelii 17XNL) to assess the contribution of the pattern recognition receptor cyclic GMP-AMP synthase (cGAS) to the development of humoral immunity. 29367469 2018
CUI: C0035369
Disease: Retroviridae Infections
Retroviridae Infections
0.010 Biomarker group BEFREE Our findings suggest that PQBP1 inhibits IFI16/cGAS-induced signaling in response to cytosolic DNA, in contrast to the role of this protein in response to retroviral infection. 29807326 2018
CUI: C0424101
Disease: Inattention
Inattention
0.010 Biomarker phenotype BEFREE Within patients carrying at least one DAT 9 allele (DAT 9/x), methylation at positions CpG2 and/or CpG6 correlated with recovery, as evident from delta-CGAS scores as well as delta Conners' scales ('inattentive' and 'hyperactive' subscales). 28822049 2018
CUI: C0424295
Disease: Hyperactive behavior
Hyperactive behavior
0.010 Biomarker phenotype BEFREE Within patients carrying at least one DAT 9 allele (DAT 9/x), methylation at positions CpG2 and/or CpG6 correlated with recovery, as evident from delta-CGAS scores as well as delta Conners' scales ('inattentive' and 'hyperactive' subscales). 28822049 2018
CUI: C0456909
Disease: Blindness
Blindness
0.010 Biomarker phenotype BEFREE Collectively, these data highlight an unexpected role of cGAS in responding to mobile-element transcripts, reveal cGAS-driven interferon signaling as a conduit for mitochondrial-damage-induced inflammasome activation, expand the immune-sensing repertoire of cGAS and caspase-4 to noninfectious human disease, and identify new potential targets for treatment of a major cause of blindness. 29176737 2018
CUI: C1332977
Disease: Childhood Leukemia
Childhood Leukemia
0.010 Biomarker disease BEFREE Importantly, we demonstrate using mice lacking DDX41 or cGAS that both sensors are needed for the full antiviral response needed to control <i>in vivo</i> MLV infection. 29871919 2018
CUI: C1536085
Disease: Geographic Atrophy
Geographic Atrophy
0.010 AlteredExpression disease BEFREE Moreover, caspase-4, gasdermin D, interferon-β, and cGAS levels were elevated in the RPE in human eyes with geographic atrophy. 29176737 2018
CUI: C0011311
Disease: Dengue Fever
Dengue Fever
0.010 Biomarker disease BEFREE Our data demonstrate a mechanism by which cGAS senses cellular damage upon DENV infection. 28346446 2017
CUI: C0024131
Disease: Lupus Vulgaris
Lupus Vulgaris
0.010 Biomarker disease BEFREE A recently discovered DNA-activated type I IFN pathway, cyclic GMP-AMP synthase (cGAS), has been linked to Aicardi-Goutières syndrome and mouse models of lupus. 27863149 2017
CUI: C0024138
Disease: Lupus Erythematosus, Discoid
Lupus Erythematosus, Discoid
0.010 Biomarker disease BEFREE A recently discovered DNA-activated type I IFN pathway, cyclic GMP-AMP synthase (cGAS), has been linked to Aicardi-Goutières syndrome and mouse models of lupus. 27863149 2017
CUI: C0409974
Disease: Lupus Erythematosus
Lupus Erythematosus
0.010 Biomarker disease BEFREE A recently discovered DNA-activated type I IFN pathway, cyclic GMP-AMP synthase (cGAS), has been linked to Aicardi-Goutières syndrome and mouse models of lupus. 27863149 2017
CUI: C3267073
Disease: Autoinflammatory disease
Autoinflammatory disease
0.010 Biomarker disease BEFREE Given its role in the innate immune response, cGAS is a promising therapeutic target for autoinflammatory disease. 28934246 2017
CUI: C3860213
Disease: Autoinflammatory disorder
Autoinflammatory disorder
0.010 AlteredExpression disease BEFREE DNA is strictly compartmentalized within the nucleus to prevent autoimmunity; despite this, cyclic GMP-AMP synthase (cGAS), a cytosolic sensor of double-stranded DNA, is activated in autoinflammatory disorders and by DNA damage. 28738408 2017
CUI: C0036220
Disease: Kaposi Sarcoma
Kaposi Sarcoma
0.010 Biomarker disease BEFREE This review summarizes the evasion strategies of host cGAS DNA sensing pathway by Kaposi's Sarcoma-associated Herpesvirus (KSHV) and their contributions to KSHV life cycles. 27933565 2016
CUI: C0940937
Disease: precancerous lesions
precancerous lesions
0.010 GeneticVariation phenotype BEFREE In conclusion, our results indicate that the rs311678 polymorphism in the cGAS gene confers genetic susceptibility to cervical precancerous lesions. 27705945 2016
CUI: C0008149
Disease: Chlamydia Infections
Chlamydia Infections
0.010 AlteredExpression group BEFREE We determined that cGAS is required for IFN-β expression during chlamydial infection in multiple cell types. 25070851 2014
CUI: C0518948
Disease: Chlamydia trachomatis infection
Chlamydia trachomatis infection
0.010 AlteredExpression disease BEFREE These novel findings provide evidence that cGAS-mediated DNA sensing directs IFN-β expression during Chlamydia trachomatis infection and suggest that effectors from infected cells can directly upregulate IFN-β expression in adjacent uninfected cells during in vivo infection, contributing to pathogenesis. 25070851 2014